Genoray Co. Ltd - Asset Resilience Ratio

Latest as of December 2025: 2.14%

Genoray Co. Ltd (122310) has an Asset Resilience Ratio of 2.14% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Genoray Co. Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩2.80 Billion

≈ $1.90 Million USD Cash + Short-term Investments

Total Assets

₩131.23 Billion

≈ $88.93 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Genoray Co. Ltd's Asset Resilience Ratio has changed over time. See Genoray Co. Ltd (122310) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Genoray Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 122310 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩2.80 Billion	2.14%
Total Liquid Assets	₩2.80 Billion	2.14%

Asset Resilience Insights

Limited Liquidity: Genoray Co. Ltd maintains only 2.14% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Genoray Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Genoray Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fleury S.A. SA:FLRY3	Diagnostics & Research	16.06%
Wuhan Thalys Med Tech Co Ltd SHG:603716	Diagnostics & Research	0.12%
Spectral Med Inc TO:EDT	Diagnostics & Research	11.67%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	60.91%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Genoray Co. Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Genoray Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.14%	₩2.80 Billion ≈ $1.90 Million	₩131.23 Billion ≈ $88.93 Million	-12.76pp
2024-12-31	14.90%	₩18.39 Billion ≈ $12.46 Million	₩123.44 Billion ≈ $83.66 Million	+2.91pp
2023-12-31	11.98%	₩14.89 Billion ≈ $10.09 Million	₩124.27 Billion ≈ $84.22 Million	-11.31pp
2022-12-31	23.29%	₩24.74 Billion ≈ $16.76 Million	₩106.20 Billion ≈ $71.97 Million	-8.99pp
2021-12-31	32.29%	₩32.08 Billion ≈ $21.74 Million	₩99.37 Billion ≈ $67.34 Million	+0.70pp
2020-12-31	31.59%	₩27.09 Billion ≈ $18.36 Million	₩85.74 Billion ≈ $58.11 Million	+0.20pp
2019-12-31	31.39%	₩24.64 Billion ≈ $16.70 Million	₩78.52 Billion ≈ $53.21 Million	+2.54pp
2018-12-31	28.85%	₩16.86 Billion ≈ $11.42 Million	₩58.44 Billion ≈ $39.60 Million	+15.72pp
2017-12-31	13.13%	₩4.95 Billion ≈ $3.36 Million	₩37.73 Billion ≈ $25.57 Million	-0.45pp
2016-12-31	13.58%	₩4.53 Billion ≈ $3.07 Million	₩33.39 Billion ≈ $22.63 Million	--

pp = percentage points

About Genoray Co. Ltd

KQ:122310 Korea Diagnostics & Research

Market Cap

$28.57 Million

₩42.15 Billion KRW

Market Cap Rank

#23981 Global

#1654 in Korea

Share Price

₩3470.00

Change (1 day)

-4.93%

52-Week Range

₩3435.00 - ₩5880.00

All Time High

₩11740.92